BEVERLY CALDWELL: Open Payments
NPI 1942604012 · GLASGOW, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$633 in 40 payments from 11 companies in 2025. Trend: 2023 $594 · 2024 $732 · 2025 $633
Food & beverage: $633
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 15 | $157 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| PFIZER INC. | 4 | $82 |
| ABBVIE INC. | 4 | $82 |
| Lilly USA, LLC | 2 | $48 |
| Exact Sciences Corporation | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Alkermes, Inc. | 1 | $17 |
Products named: REXULTI, NURTEC ODT, VRAYLAR, AIRSUPRA, MOUNJARO, Auvelity, SHINGRIX, The Cologuard Plus Collection Kit.
Industry payments across VA — which companies pay providers there.
